Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV005101535 | SCV005813209 | uncertain significance | not provided | 2024-04-02 | criteria provided, single submitter | clinical testing | This sequence change affects codon 265 of the POMC mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the POMC protein. This variant is present in population databases (rs777772852, gnomAD 0.005%). This variant has not been reported in the literature in individuals affected with POMC-related conditions. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Prevention |
RCV004531905 | SCV004715130 | likely benign | POMC-related disorder | 2021-02-17 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |